These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18351134)

  • 41. [Cutaneous features of rheumatic diseases in childhood].
    Wagner N
    Hautarzt; 2009 Mar; 60(3):200, 202-7. PubMed ID: 19277595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis.
    Flatø B; Lien G; Smerdel-Ramoya A; Vinje O
    J Rheumatol; 2009 Mar; 36(3):642-50. PubMed ID: 19208605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Transition care in pediatric rheumatology].
    Prieur AM; Deslandre C; Lemelle I
    Arch Pediatr; 2007 Jun; 14(6):665-7. PubMed ID: 17419034
    [No Abstract]   [Full Text] [Related]  

  • 44. A survey of foot problems in juvenile idiopathic arthritis.
    Hendry G; Gardner-Medwin J; Watt GF; Woodburn J
    Musculoskeletal Care; 2008 Dec; 6(4):221-32. PubMed ID: 18618460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on biologics in juvenile idiopathic arthritis.
    Ilowite NT
    Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Rheumatology update--II. Summary of clinically significant current knowledge and outlook of prospective relevant trends in etiopathogenic research, diagnostic methods and therapeutic possibilities].
    Hein G; Bolwin R; Bräuer R; Eidner T; Franke S; Oelzner P; Sprott H
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():56-64. PubMed ID: 8657087
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticytokine therapy in non-rheumatoid arthritis indications in 2009.
    Villa-Forte A
    Curr Opin Rheumatol; 2009 May; 21(3):251-5. PubMed ID: 19342955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Future trends in pediatric rheumatology.
    Fantini F
    J Rheumatol Suppl; 1993 Apr; 37():49-53. PubMed ID: 8501754
    [No Abstract]   [Full Text] [Related]  

  • 50. [Condition of organ of vision in children and adolescence with juvenile idiopathic arthritis].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2007; 109(10-12):428-31. PubMed ID: 18488388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases.
    Immonen K; Finne P; Hakala M; Kautiainen H; Pettersson T; Grönhagen-Riska C
    J Rheumatol; 2008 Jul; 35(7):1334-8. PubMed ID: 18609734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of pediatric rheumatology therapeutics.
    Becker ML
    Clin Pharmacol Ther; 2012 Apr; 91(4):597-606. PubMed ID: 22398972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis.
    Berntson L; Damgård M; Andersson-Gäre B; Herlin T; Nielsen S; Nordal E; Rygg M; Zak M; Fasth A;
    J Rheumatol; 2008 Oct; 35(10):2055-61. PubMed ID: 18785306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Juvenile idiopathic arthritis classification criteria: loopholes and diagnosis software.
    Behrens EM; Beukelman T; Cron RQ
    J Rheumatol; 2007 Jan; 34(1):234; author reply 234-5. PubMed ID: 17216696
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Discussion Meeting on Clinical update in rheumatic diseases].
    Sugii S; Suzuki M; Inoue M
    Nihon Naika Gakkai Zasshi; 2014 Oct; 103(10):2527-41. PubMed ID: 27514203
    [No Abstract]   [Full Text] [Related]  

  • 58. At the horizon of innovative therapy in rheumatology: new biologic agents.
    Finckh A; Gabay C
    Curr Opin Rheumatol; 2008 May; 20(3):269-75. PubMed ID: 18388517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Rheumatology update--I. Summary of clinically significant current knowledge and outlook of possible relevant trends in etiopathogenic research, diagnostic methods and therapeutic possibilities].
    Hein G; Bolwin R; Bräuer R; Eidner T; Franke S; Oelzner P; Sprott H
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():47-55. PubMed ID: 8657086
    [No Abstract]   [Full Text] [Related]  

  • 60. Quality improvement in pediatric rheumatology: what do we need to do?
    Passo MH; Taylor J
    Curr Opin Rheumatol; 2008 Sep; 20(5):625-30. PubMed ID: 18698189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.